ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Cypherpunk Technologies Inc.
2.75
+0.9900
56.25%
盤後：
2.70
-0.0503
-1.83%
19:59 EST
成交量：
2.63億
成交額：
7.66億
市值：
1.56億
市盈率：
-1.72
高：
3.55
開：
2.06
低：
1.89
收：
1.76
52周最高：
3.58
52周最低：
0.2223
股本：
5,665.18萬
流通股本：
4,987.71萬
量比：
1.59
換手率：
527.73%
股息：
- -
股息率：
- -
每股收益(TTM):
-1.6003
每股收益(LYR):
-1.8115
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
-1.52
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Cypherpunk Technologies Inc.
交易所：
NASDAQ
成立時間：
2011
員工人數：
52
公司地址：
47 Thorndike Street,Suite B1-1,Cambridge,Massachusetts,United States
官網：
http://www.leaptx.com
郵編：
02141
電話：
617 714 0360
傳真：
- -
簡介：
Cypherpunk Technologies Inc.最初作為Dekkun Corporation成立於2011年1月3日，是一家特拉華州公司。2025年11月13日，公司更名為Cypherpunk Technologies Inc.。該公司是一家開發新型生物標誌物靶向抗體療法的生物製藥公司，旨在通過抑制基本的腫瘤促進途徑、靶向癌症特異性細胞表面分子和利用免疫系統攻擊癌細胞來治療癌症患者。他們的策略是識別、獲取和開發分子，這些分子將迅速轉化為高影響的治療方法，產生持久的臨床效益並提高患者的預后。他們的主要臨床階段項目是DKN-01，一種抑制dickkopf相關蛋白1(“DKK1”)的單克隆抗體。他們目前正在多個正在進行的臨床試驗中研究DKN-01在食管胃癌、婦科癌症或結直腸癌患者中的應用。他們的第二個臨床階段項目是FL-301，這是一種針對細胞表面表達Claudin18.2的細胞的單克隆抗體。他們還有兩個臨床前抗體項目，FL-302和FL-501。
董事
名稱
職位
Douglas E. Onsi
Director,Chief Executive Officer and President
Khing Oei
Director and Non-Executive Chairman
Thomas Dietz
Lead Independent Director
William McEvoy
Director and Chief Investment Officer
Christian Richard
Director
Christopher K. Mirabelli
Director
James Cavanaugh
Director
Joseph Loscalzo
Director
Nissim Mashiach
Director
Patricia Martin
Director
Richard Schilsky
Director
William Li
Director
股東
名稱
職位
Douglas E. Onsi
Director,Chief Executive Officer and President
Christine Granfield
Vice President, Head of Regulatory Affairs and Quality
Jason Baum
Chief Scientific Officer
Mark O'Mahony
Chief Manufacturing Officer
William McEvoy
Director and Chief Investment Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CYPH/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYPH\",,,,,undefined,":{"symbol":"CYPH","market":"US","secType":"STK","nameCN":"Cypherpunk Technologies Inc.","latestPrice":2.75,"timestamp":1763154000000,"preClose":1.76,"halted":0,"volume":263218687,"hourTrading":{"tag":"盘后","latestPrice":2.6997,"preClose":2.75,"latestTime":"19:59 EST","volume":3543392,"amount":9502570.0282,"timestamp":1763168399545},"delay":0,"floatShares":49877123,"shares":56651840,"eps":-1.600252,"marketStatus":"休市中","change":0.99,"latestTime":"11-14 16:00:00 EST","open":2.06,"high":3.55,"low":1.8901,"amount":766250681.6738287,"amplitude":0.943125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.600252,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1763370000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.76,"preHourTrading":{"tag":"盘前","latestPrice":2.0698,"preClose":1.76,"latestTime":"09:29 EST","volume":6354910,"amount":13097256.620515,"timestamp":1763130594895},"postHourTrading":{"tag":"盘后","latestPrice":2.6997,"preClose":2.75,"latestTime":"19:59 EST","volume":3543392,"amount":9502570.0282,"timestamp":1763168399545},"volumeRatio":1.5885906267835666,"impliedVol":2.985,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYPH\",,,,,undefined,":{"symbol":"CYPH","floatShares":49877123,"roa":"--","roe":"--","lyrEps":-1.811498,"volumeRatio":1.5885906267835666,"shares":56651840,"dividePrice":0,"high":3.55,"amplitude":0.943125,"preClose":1.76,"low":1.8901,"week52Low":0.2223,"pbRate":"--","week52High":3.58,"institutionHeld":0,"latestPrice":2.75,"eps":-1.600252,"divideRate":0,"volume":263218687,"delay":0,"ttmEps":-1.600252,"open":2.06,"prevYearClose":2.875,"prevWeekClose":0.4583,"prevMonthClose":0.4472,"prevQuarterClose":0.454,"fiveDayClose":0.4583,"twentyDayClose":0.5515,"sixtyDayClose":0.275},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"CYPH","fiscalQuarterEnding":"2025/09","expectedEps":-0.24,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2025-08-14","symbol":"CYPH","fiscalQuarterEnding":"2025/06","expectedEps":-0.29,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2025-05-13","symbol":"CYPH","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-03-26","symbol":"CYPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-11-13","symbol":"CYPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1738386000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":118044172,"yearFounded":2011,"employeeNum":52,"address":"47 Thorndike Street,Suite B1-1,Cambridge,Massachusetts,United States","zipCode":"02141","officePhone":"617 714 0360"},"stockCompanyDetail":{"websiteUrl":"http://www.leaptx.com","stockEarnings":[{"period":"1week","weight":5.0004},{"period":"1month","weight":3.4071},{"period":"3month","weight":9.2574},{"period":"6month","weight":5.8579},{"period":"1year","weight":-0.0484},{"period":"ytd","weight":-0.0435}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1308},{"period":"1year","weight":0.1324},{"period":"ytd","weight":0.1465}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cypherpunk Technologies Inc.最初作為Dekkun Corporation成立於2011年1月3日，是一家特拉華州公司。2025年11月13日，公司更名為Cypherpunk Technologies Inc.。該公司是一家開發新型生物標誌物靶向抗體療法的生物製藥公司，旨在通過抑制基本的腫瘤促進途徑、靶向癌症特異性細胞表面分子和利用免疫系統攻擊癌細胞來治療癌症患者。他們的策略是識別、獲取和開發分子，這些分子將迅速轉化為高影響的治療方法，產生持久的臨床效益並提高患者的預后。他們的主要臨床階段項目是DKN-01，一種抑制dickkopf相關蛋白1(“DKK1”)的單克隆抗體。他們目前正在多個正在進行的臨床試驗中研究DKN-01在食管胃癌、婦科癌症或結直腸癌患者中的應用。他們的第二個臨床階段項目是FL-301，這是一種針對細胞表面表達Claudin18.2的細胞的單克隆抗體。他們還有兩個臨床前抗體項目，FL-302和FL-501。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.027306},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.021879},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.077902},{"month":4,"riseRate":0.444444,"avgChangeRate":0.024066},{"month":5,"riseRate":0.333333,"avgChangeRate":0.10817},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.10012},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017339},{"month":8,"riseRate":0.333333,"avgChangeRate":0.008005},{"month":9,"riseRate":0.444444,"avgChangeRate":0.109211},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.026459},{"month":11,"riseRate":0.333333,"avgChangeRate":0.497517},{"month":12,"riseRate":0.5,"avgChangeRate":0.157619}],"exchange":"NASDAQ","name":"Cypherpunk Technologies Inc.","nameEN":"Cypherpunk Technologies Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CYPH\",market:\"US\",,,undefined,":{"directors":[{"name":"Douglas E. Onsi","position":"Director,Chief Executive Officer and President"},{"name":"Khing Oei","position":"Director and Non-Executive Chairman"},{"name":"Thomas Dietz","position":"Lead Independent Director"},{"name":"William McEvoy","position":"Director and Chief Investment Officer"},{"name":"Christian Richard","position":"Director"},{"name":"Christopher K. Mirabelli","position":"Director"},{"name":"James Cavanaugh","position":"Director"},{"name":"Joseph Loscalzo","position":"Director"},{"name":"Nissim Mashiach","position":"Director"},{"name":"Patricia Martin","position":"Director"},{"name":"Richard Schilsky","position":"Director"},{"name":"William Li","position":"Director"}],"executives":[{"name":"Douglas E. Onsi","position":"Director,Chief Executive Officer and President"},{"name":"Christine Granfield","position":"Vice President, Head of Regulatory Affairs and Quality"},{"name":"Jason Baum","position":"Chief Scientific Officer"},{"name":"Mark O'Mahony","position":"Chief Manufacturing Officer"},{"name":"William McEvoy","position":"Director and Chief Investment Officer"}]}}}